Johnson & Johnson JNJ

$248.61 -15.12 (-5.73%)

Valuation

Market cap
635,562,368,000
Revenue TTM
$94,193,000,000
Net income TTM
$26,804,000,000
PE ratio
24.07
Forward PE
23.40
Profit margin
28.46%
Debt to equity
0.44

Trading

Volume
16,643,000
Avg volume
6,718,360
Day's range
$245.17 – $256.18
Shares out
2,409,898,000
Stochastic %K
18%
Beta
0.21
Analysts
Strong Sell
Price target
$282.76

Price

Company profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular...

Show more

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
732 524 0400
Website
https://www.jnj.com
Address
One Johnson & Johnson Plaza, New Brunswick, United States

Latest news

Stocktwits

RunnerSignals Oct 14, 4:28 AM
midnight market plot twist $ASTS $JNJ $AMAT $DPZ slid but each tells a different story. why weren’t stronger profits enough? read the full recap https://stocksrunner.com/news/2026-10-13-late-night-market-recap
0 replies
PadZone1 Oct 14, 3:04 AM
Great day today team. 💰 the writing has been on the wall. Just a couple dollars away from our price target on $NBIS when we reach it I’ll start to trim down and start loading more into the $GOOGL play as I think new ATH’s could definitely happen this year. Tomorrow I’ll be trading live with you all mainly focused on $SPY & $QQQ as volatility is coiling . Lastly $JNJ is headed towards a Massive LZI zone. One that can NOT Be ignored. I’ll keep you all updated with my exact entries and exits. Goodnight all ❤️ 💤 🔋
0 replies
keepingthefaith1 Oct 14, 2:57 AM
$JNJ I think this could drop more just on the chart.
0 replies
dustlesspuma Oct 14, 2:34 AM
🟢 $JNJ 257.5C Oct 23 💰 $66,800 premium 💵 $1.74/contract 📊 49.6x Vol/OI 📍 Spot $249.26 🔥 49.6x Vol/OI | 🚨 Repeat sweep 🌊 Dark Flow | Options Flow
0 replies
dustlesspuma Oct 14, 2:25 AM
🟢 $JNJ 275C Nov 06 💰 $359,900 premium 💵 $3.09/contract 📊 2.1x Vol/OI 📍 Spot $263.13 💰 Large premium 🌊 Dark Flow | Options Flow
0 replies
Undone_ai Oct 14, 2:20 AM
$JNJ Cramer is wrong on 95% of the time. I opened massive shorts.
0 replies
Etrading Oct 14, 12:54 AM
$AAPL $F $JNJ - This guy is wrong almost all of the ticker.. i cant belive so manys tupid people following him
0 replies
Srinivas111 Oct 14, 12:12 AM
$JNJ Cramer pump is a pain
0 replies